Auffarth Gerd has filed 8 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 58648 shares of Outlook Therapeutics, Inc. ($OTLK) on October 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 3, 2025 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Director | A | Stock Option (Right to Buy) | 58648 | $0.00 | 58,648.0000 | 34,796,120 | 9999.99% | 0.17% |
| Oct. 1, 2025 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Director | A | Stock Option (Right to Buy) | 286734 | $0.00 | 286,734.0000 | 34,796,120 | 9999.99% | 0.82% |
| Oct. 3, 2024 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Not found | A | Stock Option (Right to Buy) | 12082 | $0.00 | 12,082.0000 | 18,548,813 | 9999.99% | 0.07% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Not found | A | Stock Option (Right to Buy) | 56636 | $0.00 | 56,636.0000 | 18,548,813 | 9999.99% | 0.31% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Not found | A | Stock Option (Right to Buy) | 29493 | $0.00 | 29,493.0000 | 18,548,813 | 9999.99% | 0.16% |
| March 7, 2024 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Not found | A | Stock Option (Right to Buy) | 94441 | $0.00 | 94,441.0000 | 13,012,833 | 9999.99% | 0.73% |
| Oct. 4, 2023 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Director | A | Stock Option (Right to Buy) | 210225 | $0.00 | 210,225.0000 | 12,508,817 | 9999.99% | 1.68% |
| March 29, 2023 | Outlook Therapeutics, Inc. | $OTLK | Auffarth Gerd | Director | A | Stock Option (Right to Buy) | 41065 | $0.00 | 41,065.0000 | 227,410,533 | 9999.99% | 0.02% |